Inovio Biomedical Financial Statements
Inovio Biomedical Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Inovio Biomedical Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 4.8 | 3.5 | 5.5 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (15.9) | (13.4) | (15.5) |
| Total Net Income ($ mil.) | (11.2) | (12.5) | (15.3) |
| Diluted EPS (Net Income) | (0.27) | (0.46) | (1.39) |
Inovio Biomedical Quarterly Statements
| Quarter Ending Mar 08 | Quarter Ending Dec 07 | Quarter Ending Sep 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.6 | 3.3 | 0.5 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (3.3) | (1.8) | (5.0) |
| Total Net Income ($ mil.) | (3.0) | 2.0 | (4.6) |
| Diluted EPS (Net Income) | (0.07) | 0.05 | (0.10) |
Inovio Biomedical Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 9.08 | 2.13 | 1.54 |
| Price/Earnings Ratio | -- | 21.86 | 15.71 |
| Price/Book Ratio | 1.97 | 2.20 | 1.49 |
| Price/Cash Flow Ratio | -- | 15.86 | 9.65 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Inovio Biomedical Financial Ratios
Inovio Biomedical Competitive Intelligence
| Introgen Therapeutics | Targeted Genetics | Vical | |
|---|---|---|---|
| Annual Sales ($ mil.) | 1.0 | 10.3 | 5.5 |
| Employees | -- | -- | -- |
| Market Cap ($ mil.) | 38.7 | 15.0 | 136.0 |
Competitive Landscape
